Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4(+) thorn Infant ALL

M Bardini; L Trentin; F Rizzo; M Vieri; AM Savino; Patricia Garrido Castro; G Fazio; Eddy Roon van; Mark Kerstjens; N Smithers; RK Prinjha; G te Kronnie; G Basso; Ronald Stam; Rob Pieters; A Biondi; G Cazzaniga

doi:10.1158/1535-7163.mct-17-1123

Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4(+) thorn Infant ALL

M Bardini, L Trentin, F Rizzo, M Vieri, AM Savino, Patricia Garrido Castro, G Fazio, Eddy Roon van, Mark Kerstjens, N Smithers, RK Prinjha, G te Kronnie, G Basso, Ronald Stam, Rob Pieters, A Biondi, G Cazzaniga

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1705-1716
Number of pages	12
Journal	Molecular Cancer Therapeutics
Volume	17
Issue number	8
DOIs	https://doi.org/10.1158/1535-7163.mct-17-1123
Publication status	Published - 2018

Access to Document

10.1158/1535-7163.mct-17-1123

http://hdl.handle.net/1765/114272

Cite this

Bardini, M., Trentin, L., Rizzo, F., Vieri, M., Savino, AM., Garrido Castro, P., Fazio, G., Roon van, E., Kerstjens, M., Smithers, N., Prinjha, RK., te Kronnie, G., Basso, G., Stam, R., Pieters, R., Biondi, A., & Cazzaniga, G. (2018). Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4(+) thorn Infant ALL. Molecular Cancer Therapeutics, 17(8), 1705-1716. https://doi.org/10.1158/1535-7163.mct-17-1123

@article{11d57051eb8d4a089d64413a97eda5d8,

title = "Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4(+) thorn Infant ALL",

author = "M Bardini and L Trentin and F Rizzo and M Vieri and AM Savino and {Garrido Castro}, Patricia and G Fazio and {Roon van}, Eddy and Mark Kerstjens and N Smithers and RK Prinjha and {te Kronnie}, G and G Basso and Ronald Stam and Rob Pieters and A Biondi and G Cazzaniga",

year = "2018",

doi = "10.1158/1535-7163.mct-17-1123",

language = "Undefined/Unknown",

volume = "17",

pages = "1705--1716",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

Bardini, M, Trentin, L, Rizzo, F, Vieri, M, Savino, AM, Garrido Castro, P, Fazio, G, Roon van, E, Kerstjens, M, Smithers, N, Prinjha, RK, te Kronnie, G, Basso, G, Stam, R, Pieters, R, Biondi, A & Cazzaniga, G 2018, 'Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4(+) thorn Infant ALL', Molecular Cancer Therapeutics, vol. 17, no. 8, pp. 1705-1716. https://doi.org/10.1158/1535-7163.mct-17-1123

TY - JOUR

T1 - Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4(+) thorn Infant ALL

AU - Bardini, M

AU - Trentin, L

AU - Rizzo, F

AU - Vieri, M

AU - Savino, AM

AU - Garrido Castro, Patricia

AU - Fazio, G

AU - Roon van, Eddy

AU - Kerstjens, Mark

AU - Smithers, N

AU - Prinjha, RK

AU - te Kronnie, G

AU - Basso, G

AU - Stam, Ronald

AU - Pieters, Rob

AU - Biondi, A

AU - Cazzaniga, G

PY - 2018

Y1 - 2018

U2 - 10.1158/1535-7163.mct-17-1123

DO - 10.1158/1535-7163.mct-17-1123

M3 - Article

SN - 1535-7163

VL - 17

SP - 1705

EP - 1716

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 8

ER -